| Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group–6 AH Briggs, MC Weinstein, EAL Fenwick, J Karnon, MJ Sculpher, ... Medical decision making 32 (5), 722-732, 2012 | 805 | 2012 |
| Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6 AH Briggs, MC Weinstein, EAL Fenwick, J Karnon, MJ Sculpher, ... Value in Health 15 (6), 835-842, 2012 | 785 | 2012 |
| Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–4 J Karnon, J Stahl, A Brennan, JJ Caro, J Mar, J Möller Medical decision making 32 (5), 701-711, 2012 | 615 | 2012 |
| A systematic review of economic analyses of telehealth services using real time video communication VA Wade, J Karnon, AG Elshaug, JE Hiller BMC health services research 10, 1-13, 2010 | 432 | 2010 |
| Trends in healthcare incident reporting and relationship to safety and quality data in acute hospitals: results from the National Reporting and Learning System A Hutchinson, TA Young, KL Cooper, A McIntosh, JD Karnon, S Scobie, ... BMJ Quality & Safety 18 (1), 5-10, 2009 | 272 | 2009 |
| Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis. J Karnon, J Peters, J Platt, J Chilcott, E McGoogan, N Brewer Health technology assessment (Winchester, England) 8 (20), iii, 1-78, 2004 | 253 | 2004 |
| A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the rapid assessment of possible acute coronary syndrome in the emergency department … DP Chew, K Lambrakis, A Blyth, A Seshadri, MJR Edmonds, T Briffa, ... Circulation 140 (19), 1543-1556, 2019 | 239 | 2019 |
| The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: a systematic review and economic … J Carlton, J Karnon, C Czoski-Murray, KJ Smith, J Marr Health technology assessment (Winchester, England) 12 (25), iii, xi-194, 2008 | 235 | 2008 |
| Process mining for clinical processes: a comparative analysis of four Australian hospitals A Partington, M Wynn, S Suriadi, C Ouyang, J Karnon ACM Transactions on Management Information Systems (TMIS) 5 (4), 1-18, 2015 | 232 | 2015 |
| Estimating the reference incremental cost-effectiveness ratio for the Australian health system LC Edney, H Haji Ali Afzali, TC Cheng, J Karnon Pharmacoeconomics 36, 239-252, 2018 | 219 | 2018 |
| Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation J Karnon Health economics 12 (10), 837-848, 2003 | 217 | 2003 |
| Model‐based cost‐effectiveness analysis of interventions aimed at preventing medication error at hospital admission (medicines reconciliation) J Karnon, F Campbell, C Czoski‐Murray Journal of evaluation in clinical practice 15 (2), 299-306, 2009 | 192 | 2009 |
| Calibrating models in economic evaluation: a seven-step approach T Vanni, J Karnon, J Madan, RG White, WJ Edmunds, AM Foss, R Legood Pharmacoeconomics 29, 35-49, 2011 | 189 | 2011 |
| Option appraisal of population-based colorectal cancer screening programmes in England P Tappenden, J Chilcott, S Eggington, H Sakai, J Karnon, J Patnick Gut 56 (5), 677-684, 2007 | 177 | 2007 |
| A review and critique of modelling in prioritising and designing screening programmes J Karnon, E Goyder, P Tappenden, S McPhie, I Towers, J Brazier, ... HEALTH TECHNOLOGY ASSESSMENT-SOUTHAMPTON- 11 (52), 2007 | 169 | 2007 |
| Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report B John, A Roberta, A Ismail, B Jan, CS Hélène, C Bruce, C Luciane, ... Value in Health 22 (3), 267-275, 2019 | 162 | 2019 |
| Identifying existing health care services that do not provide value for money. AG Elshaug, JR Moss, P Littlejohns, J Karnon, TL Merlin, JE Hiller Medical Journal of Australia 190 (5), 2009 | 157 | 2009 |
| A systematic review of randomised controlled trials evaluating the use of patient-reported outcome measures (PROMs) S Ishaque, J Karnon, G Chen, R Nair, AB Salter Quality of Life Research 28, 567-592, 2019 | 150 | 2019 |
| The role of modelling in prioritising and planning clinical trials J Chilcott, A Brennan, A Booth, J Karnon, P Tappenden Health Technol Assess 7 (23), 1-125, 2003 | 134 | 2003 |
| The value of value of information: best informing research design and prioritization using current methods S Eckermann, J Karnon, AR Willan Pharmacoeconomics 28, 699-709, 2010 | 129 | 2010 |
Professor Adam ElshaugCentre for Health Policy, MSPGH, University of MelbourneVerified email at unimelb.edu.au